The
global Hemodynamic Monitoring
Devices Market is expected to reach USD 1.4 billion by 2024,
according to a new report by Grand View Research, Inc. The increasing demand
for non-invasive monitoring techniques coupled with the rising prevalence of
chronic illness is expected to drive the market over the forecast period.
The
hemodynamic monitoring market is influenced by new technologies such as
echocardiography, thoracic electrical bio-impedance and others that maybe used
to non-invasively monitor parameters such as cardiac output, arterial pressure,
blood oxygen level, and central venous pressure.
Furthermore,
the rising population of critically ill patients coupled with defective
healthcare facilities with drawbacks, such as understaffing, is propelling
market players to develop minimal invasive hemodynamic monitoring devices that
may be used in clinical and home care settings. Along with the new product
development, the market is also anticipated to witness the development of
technologies that help in the early diagnosis of shock and sepsis.
Furthermore,
efforts by key industry players to understand critical illnesses at molecular
levels leading to the development of efficient assessment products are expected
to be witnessed over the forecast period. Hence, all these company strategies
and the research conducted are eventually expected to promote market growth
over the forecast period.
Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market
http://www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market
Further key findings from the study suggest:
- The
disposables segment is anticipated to be the largest segment by 2024. The
rising sale of hemodynamic monitoring systems and increasing applications
of these systems in home care settings, hospitals, and clinics are expected
to boost the segment growth.
- The
non-invasive devices segment is expected to be the fastest growing
hemodynamic monitoring market. Risks that include the development of
arrhythmias due to the use of pulmonary artery catheter and the
development of other methodologies that measure the cardiac output, such
as echocardiographs, are the vital impact rendering drivers.
- Asia Pacific
is anticipated to be the fastest growing regions and is anticipated to
contribute to about 20.0% of the global revenue by 2024. The strengthening
of the distribution channels by companies and the registration of products
in countries, such as China, India, Australia, and others, are expected to
support the growth over the forecast period. For instance, LiDCO Group, in
their 2016 prelim report emphasized on its strategy of appointing new
distributors for the Australian and South East Asian region.
- Major
industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical,
Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc.,
Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical,
Inc. As mentioned above, the new product development is expected to drive
the market over the forecast period.
- For
instance, in March 2016, the LiDCO Group received the U.S. FDA approval
for the LiDCO unity and launched the product in the
European region. Along the same time, LiDCO also succeeded in registering
itself in China to explore untapped territories and increase their global
presence.
About Us:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment